Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer

Dai, Wei Fang, Beca, Jaclyn M, Nagamuthu, Chenthila et al. (5 more authors) (2022) Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer. JAMA Oncology. ISSN 2374-2445

Abstract

Metadata

Authors/Creators:
Dates:
  • Published (online): 24 February 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 01 Mar 2022 16:00
Last Modified: 26 Apr 2022 23:50
Published Version: https://doi.org/10.1001/jamaoncol.2021.8049
Status: Published online
Refereed: Yes
Identification Number: https://doi.org/10.1001/jamaoncol.2021.8049

Downloads

Filename: dai_et_al_2022_.pdf

Description: dai et al (2022)

Filename: dai_et_al_2022_supp.pdf

Description: dai et al (2022) - supp

Share / Export

Statistics